Lixte Biotechnology Holdings Inc. Warrant (LIXTW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lixte Biotechnology Holdings Inc. Warrant (LIXTW:NASDAQ), powered by AI.

Current Price
$0.02
Sector
Healthcare
What is the Lixte Biotechnology Holdings Inc. Warrant stock price forecast?

Lixte Biotechnology Holdings Inc. Warrant is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.

What is Lixte Biotechnology Holdings Inc. Warrant insider trading activity?

View the latest insider trading data for Lixte Biotechnology Holdings Inc. Warrant on Alpha Lenz.

What is Lixte Biotechnology Holdings Inc. Warrant's P/E ratio?

View Lixte Biotechnology Holdings Inc. Warrant's valuation metrics on Alpha Lenz.

Lixte Biotechnology Holdings Inc. Warrant

NASDAQ · LIXTW
$0.02+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Lixte Biotechnology Holdings Inc. Warrant's future dividend policy...
Alpha Chat Insight

Lixte Biotechnology Holdings Inc. Warrant's ROE is -148.7%. Explore profitability and growth together.

Ask for details

Company Overview

Lixte Biotechnology Holdings Inc. Warrant represents a financial derivative tied to Lixte Biotechnology Holdings Inc., a company engaged in the biotechnology sector, specifically focused on developing treatments for human cancers and other serious common diseases. The primary function of this warrant is to provide the holder with the right, but not the obligation, to purchase shares of Lixte Biotechnology common stock at a specified price before an expiration date. Such warrants are typically issued with the intent to attract investment, offering potential upside benefits if the company's stock price appreciates. Notable features of the Lixte Biotechnology Holdings Inc. Warrant include its leverage on the underlying stock, giving investors a way to gain exposure to the innovative developments in cancer treatment and biotechnology without needing to purchase shares outright. In the financial market, warrants like this serve as a tool for companies to raise capital and for investors to participate in the growth potential of emerging and cutting-edge sectors.

CEOMr. Geordan G. Pursglove
SectorHealthcare
IndustryBiotechnology
Employees2

Company Statistics

FY 2024

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
2Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-131.50%ROA
-148.73%ROE
-130.88%ROIC

Financial Health

$1.04MCash & Cash Equivalents
$-720.67KNet Debt
38.48%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lixte Biotechnology Holdings Inc. Warrant (ticker: LIXTW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 2 employees.

The current price is $0.022 with a P/E ratio of -x and P/B of -x.

ROE is -148.73%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lixte Biotechnology Holdings Inc. Warrant (LIXTW) Stock Forecast 2026 $0.02 — Price, Financials & Analyst Targets | Alpha Lenz